Korro Bio (KRRO) Cash from Investing Activities (2018 - 2026)

Korro Bio (KRRO) has 9 years of Cash from Investing Activities data on file, last reported at -$32.2 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 198.35% year-over-year to -$32.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.0 million (up 75.25% YoY) and the FY2025 annual result came in at $44.0 million, up 135.67% from the prior year.
• Cash from Investing Activities slipped to -$32.2 million in Q1 2026, from $14.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $32.8 million in Q1 2025 to a low of -$102.4 million in Q2 2024.
• A 5-year average of -$5.3 million and a median of -$1.7 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities sank 2892.2% — and 2025, when it jumped 684.23%.
• Tracing KRRO's Cash from Investing Activities over 5 years: stood at $4.5 million in 2022, then tumbled by 136.88% to -$1.7 million in 2023, then sank by 67.07% to -$2.8 million in 2024, then jumped by 639.46% to $14.9 million in 2025, then tumbled by 316.14% to -$32.2 million in 2026.
• The last three Cash from Investing Activities figures came in at -$32.2 million (Q1 2026), $14.9 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.